Viewing Study NCT00689702


Ignite Creation Date: 2025-12-25 @ 3:57 AM
Ignite Modification Date: 2026-03-27 @ 7:03 PM
Study NCT ID: NCT00689702
Status: UNKNOWN
Last Update Posted: 2012-03-26
First Post: 2008-05-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer
Sponsor: Institute of Oncology Ljubljana
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module